dc.contributor.author |
Kaswa, Ramprakash
|
|
dc.contributor.author |
Govender, Indiran
|
|
dc.date.accessioned |
2021-10-29T11:45:25Z |
|
dc.date.available |
2021-10-29T11:45:25Z |
|
dc.date.issued |
2020-06-26 |
|
dc.description.abstract |
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emergent
public health crisis threatening the current world health establishment. The SARS-Co-2 was
first identified in Wuhan, Hubei Province, China, in December 2019. There have been about
6.5 million reported cases of coronavirus disease 2019 (COVID-19) and about 350 000 reported
deaths throughout the world within the last 6 months from the onset of the epidemic.
The virus is primarily transmitted by inhalation or contact with infected droplets. The
COVID-19 patient usually presents with fever, cough, sore throat and breathlessness. Currently,
available data indicate that the majority of people with the disease have mild symptoms, while
about 20% present with moderate-to-severe disease. About 5% of these may progress to
pneumonia, acute respiratory distress syndrome and multi-organ dysfunction. To date, there
is no recommended medical treatment, and supportive measures are a crucial part of
management. The case fatality rate of SARS-CoV-2 is lower than that of its two coronavirus
predecessors, that is, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle
East respiratory syndrome coronavirus (MERS-CoV). The full impact of this new pandemic
on health, social and economic well-being of humankind is yet to be ascertained. |
en_ZA |
dc.description.department |
Family Medicine |
en_ZA |
dc.description.librarian |
am2021 |
en_ZA |
dc.description.uri |
http://www.safpj.co.za |
en_ZA |
dc.identifier.citation |
Kaswa R, Govender I. Novel
coronavirus pandemic: A
clinical overview. South African Family Practice 2020;62(1), a5123.
https://DOI.org/ 10.4102/safp.v62i1.5123. |
en_ZA |
dc.identifier.issn |
2078-6190 (print) |
|
dc.identifier.issn |
2078-6204 (online) |
|
dc.identifier.issn |
10.4102/safp. v62i1.5123 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/82322 |
|
dc.language.iso |
en |
en_ZA |
dc.publisher |
AOSIS |
en_ZA |
dc.rights |
© 2020. The Authors.
Licensee: AOSIS. This work
is licensed under the
Creative Commons
Attribution License. |
en_ZA |
dc.subject |
Coronavirus |
en_ZA |
dc.subject |
Pneumonia |
en_ZA |
dc.subject |
COVID-19 pandemic |
en_ZA |
dc.subject |
Coronavirus disease 2019 (COVID-19) |
en_ZA |
dc.subject |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
en_ZA |
dc.subject |
Infection prevention and control (IPC) |
en_ZA |
dc.subject |
Proton pump inhibitors (PPI) |
en_ZA |
dc.title |
Novel coronavirus pandemic : a clinical overview |
en_ZA |
dc.type |
Article |
en_ZA |